News & Press Releases
Filter by:
Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.
Mintz Represents Vercept in its Sale to Leading AI Company Anthropic
February 27, 2026
Mintz advised Vercept, a Seattle-based computer-use AI startup, in its sale to Anthropic, the leading AI safety and research company developing frontier-scale models and best known for its Claude family of large language models (LLMs).
5th Circuit Rejects FCC Rule, Says TCPA Allows Any Kind of Consent for Marketing Calls
February 27, 2026
Communications Daily featured insights from Member Esteban Morales in an article about a ruling from the 5th U.S. Circuit Court of Appeals which said that despite an FCC ruling that required prior written consent for telemarketing calls, the Telephone Consumer Protection Act indicates that oral consent is enough.
Mintz Advises on Eupraxia Pharmaceuticals $63.2 Million Public Offering
February 27, 2026
Mintz advised the underwriters in connection with Eupraxia Pharmaceuticals’ $63.2 million public offering.
Healthcare CDMO Deals Set for 2026 Rebound as Exits and Specialization Accelerate – Dealspeak North America
February 27, 2026
Mergermarket recently featured insights from Cheryl Reicin, Life Sciences Practice Co-chair, in an article discussing a potential 2026 rebound in M&A activity across the contract development and manufacturing organization (CDMO) sector, which provides outsourced development and manufacturing services to biopharma and medical‑device companies.
Inflexion's John DiGiovanni Sees ‘Exciting’ AI Use Cases in Healthcare; Tariff Risk Has Peaked, Victor Capital’s Doug Korn Says
February 26, 2026
PE Hub featured insights from Private Equity Practice Co-chair Matthew Simpson in an article that discusses the impact of tariffs on dealmaking.
